TICAM1 blocking peptide product blog
Tags: TICAM1; Blocking Peptide; TRIF; TICAM1 blocking peptide;
The TICAM1 ticam1 (Catalog #MBS152300) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s TRIF can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).TRIF peptide is used for blocking the activity of the TRIF antibody. Researchers should empirically determine the suitability of the TICAM1 ticam1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The TICAM1 ticam1 product has the following accession number(s) (GI #41281981) (NCBI Accession #NP_891549) (Uniprot Accession #Q8IUC6). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Species: Human
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 14 amino acids near the carboxy terminus of human TRIF. The following patways have been known to be associated with this gene. Blood, Bone, Embryonic Tissue, Heart, Intestine, Kidney, Lung, Placenta, Skin, Vascular tissues are correlated with this protein. TICAM1 also interacts with the following gene(s): IRF3, RIPK1, RIPK3, TBK1, TICAM2, TLR2, TLR3, TLR4, TRAF3, TRAF6. Carcinoma, Hepatocellular, Disease Models, Animal, Fibrosis, Inflammation, Kidney Diseases, Liver Diseases, Lung Diseases, Necrosis, Premature Birth, Respiratory Tract Diseases are some of the diseases may be linked to TRIF Peptide.